# FDA Inspection 1192631 - Bruce A. Segal, M.D. - November 29, 2022

Source: https://www.keypedia.com/records/fda_inspections/bruce-a-segal-md/026d8770-a0ed-4a26-84ed-6101727b84a8
Source feed: FDA_Inspections

> FDA Inspection 1192631 for Bruce A. Segal, M.D. on November 29, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192631
- Company Name: Bruce A. Segal, M.D.
- Inspection Date: 2022-11-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1295812 - 2025-12-18](https://www.keypedia.com/records/fda_inspections/bruce-a-segal-md/c3edf4f1-7bfb-45d4-bbb1-519d201a0174)
- [FDA Inspection 1295812 - 2025-12-18](https://www.keypedia.com/records/fda_inspections/bruce-a-segal-md/184086c3-e79f-427e-91cf-4590b229eb84)

Company: https://www.keypedia.com/companies/bruce-a-segal-md/e5c9f73b-20f8-448f-b213-11ebe8c771b0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c